Skip to content
Screener

Mirion Technologies MIR Labs and research — Total revenues

Other product segments

Nuclear power
$118.1M+43.8%
Cancer care
$62.8M+1.0%
Other
$17.8M-44.7%

Similar metrics at other companies

Quanterix Corporation logo
QTRXResearch services — Total revenues
$4.35M-22.3%
comScore logo
SCORResearch & Insight Solutions — Total revenues
$12.21M-2.7%
ALN
ALNYResearch Services Obligation — Total revenues
-$802K-106%
LanzaTech Global, Inc. logo
LNZAJoint development and contract research revenue — Total revenues
$989K-59.2%
LanzaTech Global, Inc. logo
LNZAContract research — Total revenues
$989K-28.1%
Quanterix Corporation logo
QTRXCollaboration and license revenue — Total revenues
$560K-27.4%

Other financials

Income statement

See full
Revenue$266.8M+19.7%
Gross profit$133.1M+29.9%
Operating income$17.9M+80.8%
Net income$7.7M-7.2%
EPS (diluted)$0.030.0%

Balance sheet

See full
Cash & equivalents$421.6M+60.3%
Total debt$476.6M-0.1%
Total equity$1.8B+24.9%
Total assets$3.5B+28.6%

Cash flow

See full
Operating cash flow$58.5M+372%
CapEx$10.4M+18.2%
Free cash flow$48.1M+1,236%

Valuation

See full
Market cap$3.74B-24.7%
Enterprise value$3.8B-26.7%
P/E152.7×
P/S3.7×-2.0×

Profitability

See full
Gross margin48%+1.3pp
Operating margin5.3%+0.1pp
Net margin2.4%
FCF margin13%+3.6pp

Returns & leverage

See full
Return on equity1.5%
Debt / equity0.3×-0.1×
Current ratio3.2×+0.7×

Where this comes from

Reported directly by Mirion Technologies in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Mirion Technologies’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050604
Line itemRevenues / Three Months Ended June 30, 2026Revenues / Three Months Ended June 30, 2025Revenues / Six Months Ended June 30, 2026Revenues / Six Months Ended June 30, 2025
Nuclear & Safety segment:
Nuclear$118.1$82.1$243.9$166.3
Labs and research29.127.457.454.2
Other39.032.270.454.6
Medical segment:
Cancer care62.862.2118.1111.1
Other17.819.034.638.7
Total Revenues$266.8$222.9$524.4$424.9

Item 1. Financial Statements (Unaudited)

FAQ

What is Mirion Technologies's labs and research — total revenues?
Mirion Technologies (MIR) reported labs and research — total revenues of $29.1M in Q2 2026.
How has Mirion Technologies's labs and research — total revenues changed year-over-year?
Mirion Technologies's labs and research — total revenues increased by 6.2% year-over-year, from $27.4M to $29.1M.
What is the long-term trend for Mirion Technologies's labs and research — total revenues?
Over 3 years (2022 to 2025), Mirion Technologies's labs and research — total revenues has grown at a 5.8% compound annual growth rate (CAGR), from $103.1M to $122.2M.
What does labs and research — total revenues mean?
This metric represents the total gross revenue generated from products, services, and software solutions specifically tailored for laboratory, scientific research, and analytical applications. It reflects the demand for radiation measurement and safety technologies within academic, industrial, and government research environments. Tracking this revenue stream helps investors assess the company's market penetration and growth trajectory within the specialized scientific research sector.

Ask your AI about Mirion Technologies's labs and research — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude